Adagene Inc. ADAG

Latest FY: 2025 Healthcare Biotechnology
Market Price $3.69
Market Cap $220.34M
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑7,332.8% YoY
$7.67M
3-Yr CAGR: -6.2%
Net Income ↑47.3% YoY
-$17.61M
Net Margin: -229.6%
Free Cash Flow ↑47.3% YoY
-$15.67M
FCF Yield: -7.11%
EPS (Diluted) ↑49.2% YoY
$-0.30
Basic: $-0.30
Return on Equity Efficiency
-49.8%
ROA: -22.5%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (ADAG)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2018 $1.5M $1.4M $-15.3M $-0.94 $-14.3M
FY 2019 $0.5M -68.2% $0.3M $-16.4M -7.6% $-1.10 -17.0% $-18.2M
FY 2020 $0.7M +46.0% $0.5M $-42.4M -158.0% $-2.67 -142.7% $-28.5M $-29.5M
FY 2021 $10.2M +1,351.7% $9.8M $-73.2M -72.6% $-1.46 +45.3% $-43.4M $-45.9M -55.9%
FY 2022 $9.3M -8.7% $8.6M $-80.0M -9.3% $-1.48 -1.4% $-48.6M $-49.3M -7.3%
FY 2023 $18.1M +94.9% $17.0M $-18.9M +76.3% $-0.35 +76.4% $-28.5M $-28.5M +42.1%
FY 2024 $0.1M -99.4% $0.1M $-33.4M -76.4% $-0.59 -68.6% $-29.7M $-29.7M -4.2%
FY 2025 $7.7M +7,332.8% $7.2M $-17.6M +47.3% $-0.30 +49.2% $-15.7M $-15.7M +47.3%
$

Valuation

Market Price $3.69
Market Cap $220.34M
Enterprise Value $147.81M
P/E Ratio N/A
P/B Ratio 6.18
FCF Yield -7.11%
Dividend Yield N/A
Shares Outstanding 59,231,993
%

Profitability & Margins

Gross Margin 93.96%
Operating Margin -279.48%
Net Margin -229.56%
Return on Equity (ROE) -49.82%
Return on Assets (ROA) -22.50%
Asset Turnover 0.10x
Revenue 3-Yr CAGR -6.19%
🛡️

Financial Health & Liquidity

Current Ratio 0.11
Cash Ratio 2.96
Debt / Equity 0.056
Debt / Assets 0.025
Cash & Equivalents $74.52M
Total Debt $2.00M
Book Value / Share $0.60
💧

Cash Flow Efficiency

Operating Cash Flow -$15.66M
Capital Expenditures (CapEx) $15.65K
Free Cash Flow -$15.67M
OCF / Revenue -204.11%
FCF / Revenue -204.32%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-0.30
EPS (Basic) $-0.30
Dividends / Share N/A
Book Value / Share $0.60
EPS YoY Growth 49.15%
🏛️

Balance Sheet (FY 2025)

Total Assets $78.26M
Total Liabilities $26.36M
Stockholders' Equity $35.35M
Current Assets $2.83M
Current Liabilities $25.17M